Type | Public | |
Founded | 1887 | |
HQ | New York, NY, US | Map |
Website | bms.com | |
Employee Ratings | More | |
Overall Culture | A | More |
USD | |
---|---|
Revenue (Q3, 2020) | 10.5b |
Gross profit (Q3, 2020) | 8.0b |
Gross profit margin (Q3, 2020), % | 76.3% |
Net income (Q3, 2020) | 1.9b |
Market capitalization (15-Jan-2021) | 150.4b |
Closing stock price (15-Jan-2021) | 66.5 |
Cash (30-Sept-2020) | 19.4b |
EV | 175.9b |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 1.5b | 1.9b | 3.8b | 1.7b | 3.2b | 4.5b | (766.0m) | (846.0m) | 1.0b |
Depreciation and Amortization | 143.0m | 300.0m | 465.0m | 223.0m | 443.0m | 510.0m | 2.6b | 5.0b | 7.7b |
Inventories | (4.0m) | (122.0m) | (152.0m) | 35.0m | 28.0m | (7.0m) | 1.4b | 2.1b | 2.6b |
Accounts Payable | (241.0m) | (101.0m) | (186.0m) | 136.0m | 156.0m | 48.0m | 703.0m | 480.0m | 56.0m |
USD | FY, 2017 |
---|---|
EV/CFO | 19.5 x |
Revenue/Employee | 876.6k |
Debt/Equity | 0.7 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2.8 x |
P/E Ratio | 100.5 |
Company Name | Date | Deal Size |
---|---|---|
MyoKardia | October 05, 2020 | $13.10 b |
Forbius | August 24, 2020 | |
Celgene | January 03, 2019 | $74 b |
IFM Therapeutics | August 03, 2017 | |
Cormorant Pharmaceuticals | July 05, 2016 | |
Padlock Therapeutics | March 23, 2016 | $600 m |
Cardioxyl Pharmaceuticals | November 02, 2015 | $2 b |
Flexus Biosciences | February 23, 2015 | $1.25 b |
Galecto Biotech | November 03, 2014 | $444 m |
F-star Alpha | October 28, 2014 | $475 m |
Bristol-Myers Squibb revenue breakdown by business segment: 30.3% from Eliquis, 27.6% from Opdivo, 11.4% from Orencia, 8.1% from Sprycel, 5.7% from Yervoy, 6.4% from Other Brands and 10.6% from Other
Bristol-Myers Squibb revenue breakdown by geographic segment: 58.7% from United States, 24.0% from Europe, 15.3% from Rest of World and 2.0% from Other
Bristol-Myers Squibb has 148.79k Twitter Followers. The number of followers has increased 0.3% month over month and increased 1.3% quarter over quarter
7.4k
Tweets
1.1k
Following
148.8k
Followers
20
Tweets last 30 days
9.1
Avg. likes per Tweet
100%
Tweets with engagement
A
76/100
A+
81/100
A+
85/100
A+
79/100
When was Bristol-Myers Squibb founded?
Bristol-Myers Squibb was founded in 1887.
Who are Bristol-Myers Squibb key executives?
Bristol-Myers Squibb's key executives are Giovanni Caforio, Jeff Staiger and Rupert Vessey.
How many employees does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 30,000 employees.
What is Bristol-Myers Squibb revenue?
Latest Bristol-Myers Squibb annual revenue is $26.1 b.
What is Bristol-Myers Squibb revenue per employee?
Latest Bristol-Myers Squibb revenue per employee is $871.5 k.
Who are Bristol-Myers Squibb competitors?
Competitors of Bristol-Myers Squibb include Daiichi Sankyo, Regeneron Pharmaceuticals and Gilead Sciences.
Where is Bristol-Myers Squibb headquarters?
Bristol-Myers Squibb headquarters is located at 345 Park Avenue, 345 Park Ave, New York.
Where are Bristol-Myers Squibb offices?
Bristol-Myers Squibb has offices in New York, Atlanta, Baltimore, Cambridge and in 49 other locations.
How many offices does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 55 offices.
Receive alerts for 300+ data fields across thousands of companies